Clinical Trials Directory

Trials / Unknown

UnknownNCT04057274

Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth

Effect of a Single Bout of Moderate-intensity Aerobic Exercise on Colon Cancer Cell Growth in Vitro

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
Male
Age
50 Years – 90 Years
Healthy volunteers
Accepted

Summary

This study involves drawing blood samples from men before and after they perform 30-minutes of moderate-intensity aerobic exercise. The investigators will evaluate whether adding the exercise serum to colon cancer cells in a dish can reduce the growth of the cells compared to the resting serum. Note: serum is the liquid part of the blood that carries hormones and metabolites around the body.

Detailed description

Regular exercise is associated with a reduced risk of developing colon cancer. However, the mechanisms underpinning the anti-cancer effect of exercise are not yet fully understood. A recent theory suggests that each time you exercise, the short-lasting spikes in circulating hormones can suppress the growth of cancer cells. Hence, every exercise bout could have a direct anti-cancer effect. This study will recruit men with an increased of colon cancer and explore whether incubating colon cancer cells with serum collected after a bout of moderate-intensity aerobic exercise influences cell viability in vitro.

Conditions

Interventions

TypeNameDescription
OTHERExercise assessmentThe moderate-intensity aerobic interval exercise will be performed on a cycle ergometer under the supervision of trained staff in an exercise science laboratory. Participants will perform a 5 to 10-minute warm-up that begins by pedalling against a light resistance (60 W) and progressively increases in resistance until a target heart rate of 50-60% heart rate reserve is achieved. Participants will then complete 6 x 5-minute bouts at 60% heart rate reserve whilst maintaining a cadence of 60 rev·min-1, separated by 2.5-minutes of pedalling against light resistance (60 W). The session will finish with a cool-down at light resistance (60 W) lasting 10-minutes.

Timeline

Start date
2019-09-23
Primary completion
2020-03-06
Completion
2020-09-30
First posted
2019-08-15
Last updated
2020-08-20

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04057274. Inclusion in this directory is not an endorsement.